Stem Cell Media Culture of Melanoma Results in the Induction of a Nonrepresentative Neural Expression Profile

被引:15
作者
Anaka, Matthew [1 ]
Freyer, Claudia [1 ]
Gedye, Craig [2 ]
Caballero, Otavia [3 ]
Davis, Ian D. [1 ]
Behren, Andreas [1 ]
Cebon, Jonathan [1 ]
机构
[1] Ludwig Inst Canc Res, Canc Immunobiol Lab, Melbourne Austin Branch, Melbourne, Vic 3050, Australia
[2] Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON, Canada
[3] Johns Hopkins Univ, Dept Neurosurg, Sch Med, Baltimore, MD USA
基金
英国医学研究理事会;
关键词
Melanoma; Stem cell; Cell line; Gene expression profiling; INITIATING CELLS; IDENTIFICATION; TUMORS; SUBPOPULATION; PHENOTYPE; GROWTH; SOX2;
D O I
10.1002/stem.786
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
The ability of cell lines to accurately represent cancer is a major concern in preclinical research. Culture of glioma cells as neurospheres in stem cell media (SCM) has been shown to better represent the genotype and phenotype of primary glioblastoma in comparison to serum cell lines. Despite the use of neurosphere-like models of many malignancies, there has been no robust analysis of whether other cancers benefit from a more representative phenotype and genotype when cultured in SCM. We analyzed the growth properties, transcriptional profile, and genotype of melanoma cells grown de novo in SCM, as while melanocytes share a common precursor with neural cells, melanoma frequently demonstrates divergent behavior in cancer stem cell assays. SCM culture of melanoma cells induced a neural lineage gene expression profile that was not representative of matched patient tissue samples and which could be induced in serum cell lines by switching them into SCM. There was no enrichment for expression of putative melanoma stem cell markers, but the SCM expression profile did overlap significantly with that of SCM cultures of glioma, suggesting that the observed phenotype is media-specific rather than melanoma-specific. Xenografts derived from either culture condition provided the best representation of melanoma in situ. Finally, SCM culture of melanoma did not prevent ongoing acquisition of DNA copy number abnormalities. In conclusion, SCM culture of melanoma does not provide a better representation of the phenotype or genotype of metastatic melanoma, and the resulting neural bias could potentially confound therapeutic target identification. STEM CELLS 2012; 30:336343.
引用
收藏
页码:336 / 343
页数:8
相关论文
共 26 条
[1]
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival [J].
Bogunovic, Dusan ;
O'Neill, David W. ;
Belitskaya-Levy, Ilana ;
Vacic, Vladimir ;
Yu, Yi-Lo ;
Adams, Sylvia ;
Darvishian, Farbod ;
Berman, Russell ;
Shapiro, Richard ;
Pavlick, Anna C. ;
Lonardi, Stefano ;
Zavadil, Jiri ;
Osman, Iman ;
Bhardwaj, Nina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) :20429-20434
[2]
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 [J].
Boiko, Alexander D. ;
Razorenova, Olga V. ;
van de Rijn, Matt ;
Swetter, Susan M. ;
Johnson, Denise L. ;
Ly, Daphne P. ;
Butler, Paris D. ;
Yang, George P. ;
Joshua, Benzion ;
Kaplan, Michael J. ;
Longaker, Michael T. ;
Weissman, Irving L. .
NATURE, 2010, 466 (7302) :133-U155
[3]
Isolation and culture of colon cancer stem cells [J].
Cammareri, Patrizia ;
Lombardo, Ylenia ;
Francipane, Maria Giovanna ;
Bonventre, Sebastino ;
Todaro, Matilde ;
Stassit, Giorgio .
STEM CELL CULTURE, 2008, 86 :311-+
[4]
CANCER STEM CELLS Invitation to a second round [J].
Dirks, Peter .
NATURE, 2010, 466 (7302) :40-41
[5]
Identification and expansion of the tumorigenic lung cancer stem cell population [J].
Eramo, A. ;
Lotti, F. ;
Sette, G. ;
Pilozzi, E. ;
Biffoni, M. ;
Di Virgilio, A. ;
Conticello, C. ;
Ruco, L. ;
Peschle, C. ;
De Maria, R. .
CELL DEATH AND DIFFERENTIATION, 2008, 15 (03) :504-514
[6]
A tumorigenic subpopulation with stem cell properties in melanomas [J].
Fang, D ;
Nguyen, TK ;
Leishear, K ;
Finko, R ;
Kulp, AN ;
Hotz, S ;
Van Belle, PA ;
Xu, XW ;
Elder, DE ;
Herlyn, M .
CANCER RESEARCH, 2005, 65 (20) :9328-9337
[7]
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells [J].
Gedye, Craig ;
Quirk, Juliet ;
Browning, Judy ;
Svobodova, Suzanne ;
John, Thomas ;
Sluka, Pavel ;
Dunbar, P. Rod ;
Corbeil, Denis ;
Cebon, Jonathan ;
Davis, Ian D. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (10) :1635-1646
[8]
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature [J].
Hoek, Keith S. ;
Schlegel, Natalie C. ;
Brafford, Patricia ;
Sucker, Antje ;
Ugurel, Selma ;
Kumar, Rajiv ;
Weber, Barbara L. ;
Nathanson, Katherine L. ;
Phillips, David J. ;
Herlyn, Meenhard ;
Schadendorf, Dirk ;
Dummer, Reinhard .
PIGMENT CELL RESEARCH, 2006, 19 (04) :290-302
[9]
In vivo switching of human melanoma cells between proliferative and invasive states [J].
Hoek, Keith S. ;
Eichhoff, Ossia M. ;
Schlegel, Natalie C. ;
Doebbeling, Udo ;
Kobert, Nikita ;
Schaerer, Leo ;
Hemmi, Silvio ;
Dummer, Reinhard .
CANCER RESEARCH, 2008, 68 (03) :650-656
[10]
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues [J].
Jaeger, Jochen ;
Koczan, Dirk ;
Thiesen, Hans-Juergen ;
Ibrahim, Saleh M. ;
Gross, Gerd ;
Spang, Rainer ;
Kunz, Manfred .
CLINICAL CANCER RESEARCH, 2007, 13 (03) :806-815